EUCTR2005-001212-44-IT进行中（未招募）不适用
etrozole adjuvant therapy duration (LEAD)study: standard versus long treatment. A phase III study in postmenopausal women with early breast cancer
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A Phase III Study to Evaluate Letrozole as Adjuvant Endocrina Therapy for Postmenopausal Women with Receptor (ER and/or PgR) Positive Tumors-C509 Breast, unspecifiedBreast, unspecifiedC509PER-051-00OVARTIS BIOSCIENSES PERU S.A.,
已完成
3 期
Adjuvant Therapy for Postmenopausal Patients with Operable Breast Cancer who have Estrogen Receptor or Progesterone Receptor Positive Tumors.Tamoxifen vs. Letrozole vs. Tamoxifen followed by Letrozole vs. Letrozole followed by TamoxifeBreast CancerACTRN12607000012471ovartis Pharma AG, Basel6,193
已完成
2 期
Evaluation of efficacy of Letrozole on the duration and severity of Ovarian hyperstimulation syndromeIRCT20141008019464N2Kerman University of Medical Sciences40
进行中（未招募）
不适用
etrozole adjuvant therapy after tamoxifen. Study of gene CYP19 correlation with letrozole efficacy in postmenopausal early breast cancer patientsPatients selection to give letrozole for 5 years after 5 years of tamoxifen as adjuvant hormonal therapyMedDRA version: 14.1Level: PTClassification code 10057654Term: Breast cancer femaleSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2005-001213-18-ITCONSORZIO ONCOTECH
进行中（未招募）
不适用
A Phase II study evaluating intermittent letrozole as adjuvant endocrine therapy for postmenopausal women with hormone-receptor positive, early stage breast cancer - NDhormone receptor positive breast cancerMedDRA version: 9.1Level: LLTClassification code 10057654Term: Breast cancer femaleEUCTR2007-002059-18-ITISTITUTO EUROPEO DI ONCOLOGIA